140 related articles for article (PubMed ID: 10506134)
1. Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis.
Jockers R; Angers S; Da Silva A; Benaroch P; Strosberg AD; Bouvier M; Marullo S
J Biol Chem; 1999 Oct; 274(41):28900-8. PubMed ID: 10506134
[TBL] [Abstract][Full Text] [Related]
2. Differences in endosomal targeting of human (beta)1- and (beta)2-adrenergic receptors following clathrin-mediated endocytosis.
Liang W; Curran PK; Hoang Q; Moreland RT; Fishman PH
J Cell Sci; 2004 Feb; 117(Pt 5):723-34. PubMed ID: 14734649
[TBL] [Abstract][Full Text] [Related]
3. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies.
Longva KE; Blystad FD; Stang E; Larsen AM; Johannessen LE; Madshus IH
J Cell Biol; 2002 Mar; 156(5):843-54. PubMed ID: 11864992
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments.
Rocca A; Lamaze C; Subtil A; Dautry-Varsat A
Mol Biol Cell; 2001 May; 12(5):1293-301. PubMed ID: 11359922
[TBL] [Abstract][Full Text] [Related]
6. Properties of secretin receptor internalization differ from those of the beta(2)-adrenergic receptor.
Walker JK; Premont RT; Barak LS; Caron MG; Shetzline MA
J Biol Chem; 1999 Oct; 274(44):31515-23. PubMed ID: 10531354
[TBL] [Abstract][Full Text] [Related]
7. Degradation of the G protein-coupled receptor kinase 2 by the proteasome pathway.
Penela P; Ruiz-Gómez A; Castaño JG; Mayor F
J Biol Chem; 1998 Dec; 273(52):35238-44. PubMed ID: 9857063
[TBL] [Abstract][Full Text] [Related]
8. Resistance of the human beta1-adrenergic receptor to agonist-induced ubiquitination: a mechanism for impaired receptor degradation.
Liang W; Fishman PH
J Biol Chem; 2004 Nov; 279(45):46882-9. PubMed ID: 15331590
[TBL] [Abstract][Full Text] [Related]
9. Modulation of postendocytic sorting of G protein-coupled receptors.
Whistler JL; Enquist J; Marley A; Fong J; Gladher F; Tsuruda P; Murray SR; Von Zastrow M
Science; 2002 Jul; 297(5581):615-20. PubMed ID: 12142540
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
Li JG; Benovic JL; Liu-Chen LY
Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
[TBL] [Abstract][Full Text] [Related]
11. Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor.
Dupré DJ; Chen Z; Le Gouill C; Thériault C; Parent JL; Rola-Pleszczynski M; Stankova J
J Biol Chem; 2003 Nov; 278(48):48228-35. PubMed ID: 14500726
[TBL] [Abstract][Full Text] [Related]
12. Constitutive endocytosis and degradation of the pre-T cell receptor.
Panigada M; Porcellini S; Barbier E; Hoeflinger S; Cazenave PA; Gu H; Band H; von Boehmer H; Grassi F
J Exp Med; 2002 Jun; 195(12):1585-97. PubMed ID: 12070286
[TBL] [Abstract][Full Text] [Related]
13. Cell adhesion regulates ubiquitin-mediated degradation of the platelet-derived growth factor receptor beta.
Baron V; Schwartz M
J Biol Chem; 2000 Dec; 275(50):39318-23. PubMed ID: 11007771
[TBL] [Abstract][Full Text] [Related]
14. A primate-dominant third glycosylation site of the beta2-adrenergic receptor routes receptors to degradation during agonist regulation.
Mialet-Perez J; Green SA; Miller WE; Liggett SB
J Biol Chem; 2004 Sep; 279(37):38603-7. PubMed ID: 15247302
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of phosphoinositide 3-kinase cause defects in the postendocytic sorting of beta2-adrenergic receptors.
Awwad HO; Iyer V; Rosenfeld JL; Millman EE; Foster E; Moore RH; Knoll BJ
Exp Cell Res; 2007 Jul; 313(12):2586-96. PubMed ID: 17553490
[TBL] [Abstract][Full Text] [Related]
16. Effects of the β-agonist, isoprenaline, on the down-regulation, functional responsiveness and trafficking of β2-adrenergic receptors with N-terminal polymorphisms.
Koryakina Y; Jones SM; Cornett LE; Seely K; Brents L; Prather PL; Kofman A; Kurten RC
Cell Biol Int; 2012; 36(12):1171-83. PubMed ID: 22938397
[TBL] [Abstract][Full Text] [Related]
17. Role of clathrin-mediated endocytosis in agonist-induced down-regulation of the beta2-adrenergic receptor.
Gagnon AW; Kallal L; Benovic JL
J Biol Chem; 1998 Mar; 273(12):6976-81. PubMed ID: 9507004
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins.
van Kerkhof P; Alves dos Santos CM; Sachse M; Klumperman J; Bu G; Strous GJ
Mol Biol Cell; 2001 Aug; 12(8):2556-66. PubMed ID: 11514635
[TBL] [Abstract][Full Text] [Related]
19. Type-specific sorting of G protein-coupled receptors after endocytosis.
Tsao PI; von Zastrow M
J Biol Chem; 2000 Apr; 275(15):11130-40. PubMed ID: 10753919
[TBL] [Abstract][Full Text] [Related]
20. Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors.
Pierce KL; Maudsley S; Daaka Y; Luttrell LM; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1489-94. PubMed ID: 10677489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
